Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients

NCT04906213 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04906213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Terminated
Start date
July 25, 2022
Completion date
January 22, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, kidney transplant; complications